Published in BJU Int on August 26, 2010
Commentary on the myths of Peyronie's disease. Transl Androl Urol (2012) 0.75
Surgeries in andrology: optimization and patients' well being. Asian J Androl (2012) 0.75
Innovative surgical techniques for managing Peyronie's disease: a video presentation. Transl Androl Urol (2013) 0.75
Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol (2002) 1.96
Graft materials in Peyronie's disease surgery: a comprehensive review. J Sex Med (2007) 1.66
CONGENITAL CURVATURE OF THE PHALLUS: REPORT OF THREE CASES WITH DESCRIPTION OF CORRECTIVE OPERATION. J Urol (1965) 1.37
L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide (2003) 1.31
Application of pericardial graft in the surgical management of Peyronie's disease. J Urol (2000) 1.10
Straightening corporoplasty for Peyronie's disease: a review of 218 patients with median follow-up of 89 months. Eur Urol (2004) 1.08
Treatment of Peyronie's disease with oral pentoxifylline. Nat Clin Pract Urol (2006) 1.03
Nesbit procedure for disabling Peyronie's curvature: a median follow-up of 84 months. Urology (2003) 1.02
Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up. J Sex Med (2008) 1.01
The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease. BJU Int (2005) 1.01
Anatomy and strength of the tunica albuginea: its relevance to penile prosthesis extrusion. J Urol (1994) 0.99
Venous patch graft for Peyronie's disease. Part II: outcome analysis. J Urol (1998) 0.94
Long-term results of autologous venous grafts for penile morphological reconstruction. J Androl (2006) 0.91
Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's disease. Urology (2001) 0.90
Human penile ossification: case report. Sao Paulo Med J (2007) 0.89
Surgical treatment of Peyronie's disease by the intracavernosal plaque excision method: a new surgical technique. Eur Urol (2004) 0.85
Minimally invasive intracorporeal incision of Peyronie's plaque: initial experiences with a new technique. Urology (2006) 0.82
Venous grafting for the correction of penile curvature in Peyronie's disease. Curr Opin Urol (1998) 0.82
Peyronie's disease: excision of the plaque and grafting with tunica vaginalis. Urol Clin North Am (1982) 0.79
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science (2003) 3.19
Origin, adaptive radiation and diversification of the Hawaiian lobeliads (Asterales: Campanulaceae). Proc Biol Sci (2009) 3.18
Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63
Molecular mechanisms related to parturition-induced stress urinary incontinence. Eur Urol (2008) 2.17
Increased risk of high-grade prostate cancer among infertile men. Cancer (2010) 2.00
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol (2002) 1.96
Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol (2010) 1.95
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93
An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med (2014) 1.91
Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2010) 1.87
Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am (2005) 1.81
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation (2006) 1.73
Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy (2010) 1.71
T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol (2009) 1.69
Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signalling pathway in the major pelvic ganglion of the rat after cavernous nerve transection. Eur Urol (2006) 1.67
Brain activation and sexual arousal in healthy, heterosexual males. Brain (2002) 1.62
Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol (2007) 1.57
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Penile sonographic and clinical characteristics in men with Peyronie's disease. J Sex Med (2009) 1.55
Socioeconomic, anthropomorphic, and demographic predictors of adult sexual activity in the United States: data from the national survey of family growth. J Sex Med (2009) 1.54
Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol (2002) 1.54
Costs of infertility treatment: results from an 18-month prospective cohort study. Fertil Steril (2010) 1.53
Racial differences in vasectomy utilization in the United States: data from the national survey of family growth. Urology (2009) 1.53
The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J Sex Med (2010) 1.50
Erection of the human penis and its morphological and vascular basis by Guiseppe Conti. J Sex Med (2008) 1.45
Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy (2009) 1.45
Prevalence and predictors of sexual problems, relationship stress, and depression in female partners of infertile couples. J Sex Med (2008) 1.45
Effects of high glucose on human cavernous endothelial cells. Urology (2012) 1.44
Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev (2011) 1.44
Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev (2012) 1.44
Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells. Urology (2011) 1.43
Improving erectile function by silencing phosphodiesterase-5. J Urol (2005) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Phimosis with Preputial Fissures as a Predictor of Undiagnosed Type 2 Diabetes in Adults. Acta Derm Venereol (2016) 1.39
The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States. Fertil Steril (2010) 1.39
The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int (2004) 1.37
Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med (2008) 1.35
Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer (2012) 1.35
A pathophysiology-based approach to the management of early priapism. Asian J Androl (2012) 1.35
Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med (2010) 1.35
T-shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int (2008) 1.33
Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med (2012) 1.30
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int (2007) 1.27
Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int (2005) 1.24
Peyronie's disease (CME). J Sex Med (2007) 1.24
Up-regulation of estrogen responsive genes in hypospadias: microarray analysis. J Urol (2007) 1.23
Expression, distribution and regulation of phosphodiesterase 5. Curr Pharm Des (2006) 1.20
Label retaining and stem cell marker expression in the developing rat urinary bladder. Urology (2011) 1.19
Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev (2012) 1.18
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol (2011) 1.17
Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol (2010) 1.17
Long-term effect of ovariectomy and simulated birth trauma on the lower urinary tract of female rats. J Urol (2002) 1.17
Adipose tissue-derived stem cells secrete CXCL5 cytokine with neurotrophic effects on cavernous nerve regeneration. J Sex Med (2010) 1.16
Sexual, marital, and social impact of a man's perceived infertility diagnosis. J Sex Med (2009) 1.16
Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate (2010) 1.15
Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J Sex Med (2011) 1.14
Altered expression patterns of TCP and MYB genes relating to the floral developmental transition from initial zygomorphy to actinomorphy in Bournea (Gesneriaceae). New Phytol (2008) 1.13
Time costs of fertility care: the hidden hardship of building a family. Fertil Steril (2013) 1.13
Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev (2009) 1.12
Recent advances in andrology-related stem cell research. Asian J Androl (2008) 1.09
The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence. BJU Int (2005) 1.08
Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med (2010) 1.08
Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief? BJU Int (2009) 1.07
Evolution of Cyrtandra (Gesneriaceae) in the Pacific Ocean: the origin of a supertramp clade. Am J Bot (2005) 1.07
Nerve growth factor modulation of the cavernous nerve response to injury. J Sex Med (2009) 1.06
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV. Bioorg Med Chem Lett (2013) 1.05
Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2008) 1.05
Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges. Histol Histopathol (2013) 1.05
Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol (2003) 1.05
Identification of active and quiescent adipose vascular stromal cells. Cytotherapy (2011) 1.04
Potential of adipose-derived stem cells for treatment of erectile dysfunction. J Sex Med (2009) 1.04
The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol (2002) 1.04
U.S. national statistics on penile fracture. J Sex Med (2010) 1.03
Treatment of Peyronie's disease with oral pentoxifylline. Nat Clin Pract Urol (2006) 1.03
Tissue distribution of mesenchymal stem cell marker Stro-1. Stem Cells Dev (2011) 1.02
Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med (2005) 1.02
Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort. Fertil Steril (2010) 1.02
Recreational urethral sounding is associated with high risk sexual behaviour and sexually transmitted infections. BJU Int (2012) 1.01
Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI. Nanomedicine (Lond) (2013) 1.01
Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction. Urology (2011) 1.00
Slo1 is the principal potassium channel of human spermatozoa. Elife (2013) 1.00
Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties. Biochem Biophys Res Commun (2010) 1.00
Both immediate and delayed intracavernous injection of autologous adipose-derived stromal vascular fraction enhances recovery of erectile function in a rat model of cavernous nerve injury. Eur Urol (2012) 0.99